According to clinical studies, 63% of patients with primary colorectal cancer had the FBN2 gene methylated in their tumour samples; this suggests that FBN2 may be a novel diagnostic for the hepatic metastases of colorectal cancer [43]. The gene discussed is FBN2; the disease is neoplasm.